Ravasio, R., Antonelli, S., Rogai, V., Fakhouri, W., Capron, J. P., & Losi, S. (2018). Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy. Global and Regional Health Technology Assessment, 5(1). https://doi.org/10.33393/grhta.2018.435